Continuous Analyte Monitoring for Real-Time GLP-1 Therapy Guidance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the effectiveness of GLP-1 medications face challenges in accurately and efficiently monitoring weight loss, managing gastrointestinal symptoms, and ensuring patient compliance due to reliance on sporadic point-in-time measurements, which can lead to non-compliance and negative side effects.
Innovation Solution
A continuous analyte monitoring system that tracks glucose, lactate, ketones, glycerol, and free fatty acid levels to optimize GLP-1 regimens, providing real-time therapy management guidance for diet, exercise, and medication adjustments to minimize side effects and maintain weight loss.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If point-in-time measurements are used to monitor weight loss and medication effectiveness, then the measurement process is simple and quick, but the accuracy and reliability of monitoring is insufficient leading to non-compliance and negative side effects
Solution Approach 1:
The patent implements continuous monitoring of weight loss and medication effectiveness through ongoing data collection and analysis, replacing intermittent point-in-time measurements with continuous tracking. This allows the system to monitor patient progress in real-time, providing timely feedback to adjust medication dosing and prevent negative side effects before they occur.
Solution Approach 2:
The system continuously collects patient data on weight loss, medication adherence, and side effects, then provides feedback to both patients and providers. This feedback loop enables real-time adjustments to medication regimens based on actual patient response, improving monitoring accuracy while maintaining timely interventions to prevent non-compliance and adverse effects.
2Reliability
If continuous monitoring is implemented to optimize GLP-1 regimens, then patient compliance and side effect management improve, but the complexity of the monitoring system increases
Solution Approach 1:
The monitoring system is designed to perform multiple functions through a single integrated platform: tracking weight loss, monitoring medication adherence, detecting side effects, providing personalized feedback, and enabling provider adjustments. This multi-functional approach improves reliability and patient compliance while managing system complexity by consolidating multiple monitoring tasks into one unified system.
Solution Approach 2:
The system automatically collects patient data, analyzes progress, generates personalized feedback, and provides therapy management guidance without requiring manual intervention. This self-service capability reduces the burden on both patients and providers, improving compliance through automated reminders and real-time feedback while managing complexity through algorithm-driven operations rather than manual processes.
3Productivity
If real-time therapy management guidance is provided, then medication effectiveness is optimized, but the information processing requirements and system complexity increase
Solution Approach 1:
The system pre-establishes personalized therapy management guidance and intervention protocols based on patient profiles and historical data. When monitoring data triggers predetermined thresholds or patterns, pre-planned actions are automatically executed, such as sending alerts to providers or generating personalized feedback messages. This preliminary preparation enables real-time optimization while reducing processing complexity by using pre-defined decision rules rather than complex real-time calculations.
Solution Approach 2:
The system dynamically adjusts monitoring parameters, feedback frequency, and intervention thresholds based on individual patient responses and progress. By tailoring the intensity and timing of therapy management guidance to each patient's specific needs, the system achieves high productivity in optimization while managing information processing complexity through personalized parameter adaptation rather than uniform high-intensity monitoring for all patients.
Data Source
AI summary
Certain aspects of the present disclosure provide a monitoring system comprising a continuous analyte sensor configured to penetrate a skin of a patient and generate a sensor current indicative of analyte levels of the patient, and a sensor electronics module coupled to the continuous analyte sensor. The sensor electronics module comprises an analog to digital converter configured to receive the sensor current and convert the sensor current generated by the continuous analyte sensor into digital signals, one or more processors configured to convert the digital signals to a set of analyte measurements indicative of the analyte levels of the patient, and a Bluetooth antenna configured to transmit the set of analyte measurements wirelessly to a wireless communications device using Bluetooth or BLE communications protocols.